Plain-English translation of NCT06091774 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is testing a smartphone app called iATROS that's designed to help people with coronary heart disease (a condition where the heart's blood vessels are narrowed or blocked) manage their risk factors and stay healthier. About half of the participants will use the app along with their regular doctor's care, while the other half will receive standard care only. The study will follow everyone for 18 months to see whether the app helps people control things like blood pressure, cholesterol, and other health markers.
Many people with heart disease struggle to stick with medications and lifestyle changes that could prevent future problems. This trial wants to see if using an easy-to-access tool on a smartphone can help people take better care of themselves and manage their condition more effectively.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly assigned to either use the iATROS app along with standard care or to receive standard care alone. If you get the app, you'll receive devices to measure your vital signs at home and use the app to track and manage your health for 9 months, then continue using it for another 9 months to see how well the improvements last. During the first 9 months, you'll have regular check-ins; after that, researchers will monitor whether the benefits of using the app stay stable. The entire study lasts 18 months.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany